Skip to main content
. 2019 Jun 15;199(12):1517–1536. doi: 10.1164/rccm.201712-2410OC

Table 1.

Characteristics of Patients with Pulmonary Fibrosis

Age (yr) Sex Diagnosis History of Smoking Supplemental Oxygen Use before Transplant Sample ID
66* M IPF Yes Yes IPF 1
60* M IPF No Yes IPF 2
68* M IPF Yes Yes IPF 3
72* F IPF No Yes IPF 4
55* F Hypersensitivity pneumonitis No Yes HP
39* F Systemic sclerosis–associated ILD No Yes SSc-ILD 1
53* F Systemic sclerosis–associated ILD No Yes SSc-ILD 2
37* F Myositis-associated ILD No Yes PM-ILD
71 F IPF Yes No Cryobiopsy
42 M Systemic sclerosis–associated ILD No Yes NA
65 M IPF No Yes NA
52 M Systemic sclerosis–associated ILD Yes Yes NA
52 F Systemic sclerosis–associated ILD No Yes NA
55 F Myositis-associated ILD No Yes NA
56 F Hypersensitivity pneumonitis No Yes NA
60 M Myositis-associated ILD Yes Yes NA
67 M IPF Yes No NA

Definition of abbreviations: HP = hypersensitivity pneumonitis; ILD = interstitial lung disease; IPF = idiopathic pulmonary fibrosis; NA = not applicable; PM = polymyositis; SSc = systemic sclerosis.

Representative histopathology with pathologist interpretation is found in Figure E1A.

*

Transplant recipients with pulmonary fibrosis included in single-cell RNA-Seq analysis.

Patient with IPF undergoing cryobiopsy included in single-cell RNA-Seq analysis.

Transplant recipients with pulmonary fibrosis included in bulk RNA-Seq analysis.